Even though anemia is not as common in the United States (affecting roughly 10 percent of people) as it is worldwide (affecting nearly 30 percent of people), it often affects more women than men and ...

Roxadustat advances as a promising oral treatment for anemia in lower-risk myelodysplastic syndromes, targeting high ...

Someone in the U.S. requires a blood transfusion every two seconds; over 12 million units of blood are needed to transfuse more than 4.5 million Americans every year.

Half didn't receive blood unless their blood count was less than eight g/dL, the restrictive transfusion strategy. All patients in the study had a heart attack and anemia, meaning they had a ...

Anemia affects almost 1 in 4 people worldwide. But while billions of people live with the disease, its signs and symptoms aren't just part of everyday life. "Anemia is one of the most common ...

Beta-thalassemia and MDS can cause anemia. Reblozyl is approved to treat anemia if you have either of these conditions. Reblozyl increases the number of red blood cells by allowing immature red ...

Detailed price information for Fibrogen Inc CS (FGEN-Q) from The Globe and Mail including charting and trades.

In patients with anemia who present with MI, a restrictive blood transfusion strategy was noninferior to liberal transfusion for preventing major adverse CV events at 30 days, according to results ...

Technological advances and new tools may offer the best chance to help underdeveloped blood deserts in the short term.

Transfusion-dependent Beta thalassemia major is the most severe type. It often starts by age 2 and causes severe anemia and other serious symptoms. Treatment involves regular blood transfusions.

Om Prakash, Papali younger brother, emerged as a perfect match. At a young age, the lad donated his blood stem cells. On ...